CF research knowledge exchange

There is no question that knowledge is power. And sharing it is even more powerful. We are proud to be leaders in the cystic fibrosis research community and excited to share and learn with our cystic fibrosis research colleagues in Canada and around the world.

Watch: Cystic Fibrosis Canada President & CEO Kelly Grover shares takeaways from the 24 NACFC

Save the Date

Cystic Fibrosis Canada hosts the first Canadian Cystic Fibrosis Conference in Calgary, Alberta on September 18 and 19, 2025 (with an evening reception on September 17). We look forward to bringing together Canadian cystic fibrosis clinic staff and researchers to shape the future of CF care in Canada. Stay tuned for registration and agenda information.

Read: Stories on cystic fibrosis researchers and their research

Researcher handling containers of medicines to be tested

Improving equitable access to clinical trials in Quebec

Discover how Cystic Fibrosis Canada’s clinical trials network, CF CanACT, is improving access to clinical trials for French-speaking Canadians with CF.

Research

Dr. Jonathan Dennis new unexplored approach to treatment of dangerous bacteria

Dr. Jonathan Dennis researches phage therapy for Burkholderia CF lung infections, funded by Cystic Fibrosis Canada, to help the CF community fight dangerous bacteria.

Research

Unmasking Resistance: Dr. Omar El-Halfawy's Pioneering Approach to Antibiotic Resistance in CF

Dr. Omar El-Halfawy’s research fights antibiotic resistance in CF by improving testing and uncovering new treatments for stubborn lung infections.

Research

Dr. Zongchao Jia on developing new therapies for Pseudomonas Aeruginosa

Dr. Zongchao Jia is a professor and researcher at Queen’s University who was recently funded by Cystic Fibrosis Canada for his research study, Investigation of P. aeruginosa polyphosphate kinases and their role in host cell infection for developing novel CF therapeutics. Learn more about Dr. Jia and his contribution to cystic fibrosis research.

Research

Harnessing genetic information: Dr. Bowen Li's bold vision for cystic fibrosis

Dr. Bowen Li is transforming the landscape of cystic fibrosis (CF) treatment with his pioneering work in RNA-based therapies. His bold vision aims to turn CF from a fatal disease into a manageable condition, using advanced RNA technology to tackle the disease at its genetic roots.

Check out our Elevate program

Canadians living with cystic fibrosis and their families and caregivers are helping to determine the research we fund. Elevate members are making a meaningful impact on CF research in Canada through their role as Community Reviewers for Cystic Fibrosis Canada and their participation and consultation in third-party research projects across the country. Thanks for this knowledge exchange!

Explore Elevate